- Finalization of agreement with additional distribution
partner allows access into another key European
market
- Medical Innovation Solutions is a well-established partner
with deep existing relationships in neurosurgical
space
STOCKHOLM, Dec. 17, 2020 /PRNewswire/ -- IRRAS AB, a
commercial-stage medical technology company with a comprehensive
portfolio of innovative products for neurocritical care, today
announced an exclusive distribution agreement with Medical
Innovation Solutions, a leading distributor of world-class
neurosurgical medical devices and technologies throughout
Southeastern Europe, including the
key markets of Serbia, Croatia,
Romania, North Macedonia, Slovenia and Hungary."
We are pleased to partner with Medical Innovation Solutions to
expand the commercial availability of our IRRAflow product
line to physicians and patients throughout southeastern
Europe," said Coenraad Tamse, Vice President of International
Sales for IRRAS. "This partnership expands the IRRAflow
launch into a new geographic region of Europe by partnering with a leading
distributor that successfully sells a complementary product
portfolio that targets a hospital's intensive care unit (ICU)."
Saša Pozder, Managing Director of Medical Innovation Solutions,
commented, "We are excited to add IRRAflow to our product
portfolio because we can now offer patients a next generation
solution for intracranial bleeding. This exclusive distribution
agreement builds upon our history of success in launching leading
medical technologies to our clients. We plan to focus our early
efforts in Serbia and Croatia and
will build upon this initial success by expanding into the broader
geography."
About IRRAS
IRRAS is a global medical care company focused on delivering
innovative medical solutions to improve the lives of critically ill
patients. IRRAS designs, develops, and commercializes neurocritical
care products that transform patient outcomes and decrease the
overall cost of care by addressing complications associated with
current treatment methodologies. IRRAS markets and sells its
comprehensive, innovative IRRAflow and Hummingbird ICP
Monitoring product lines to hospitals worldwide through its direct
sales organization in the United
States and select European countries as well as an
international network of distribution partners.
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in
Munich, Germany, and San Diego, California, USA. For more
information, please visit www.irras.com.
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
For more information, please contact:
USA
Kleanthis G. Xanthopoulos
Ph.D.
CEO
ir@irras.com
Europe
Sabina Berlin
CFO
+46 73 951 95 02
sabina.berlin@irras.com
The information was released for public disclosure, through
the agency of the contact person above, on December 17, 2020 at 08:00 (CET).
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/irras/r/irras-announces-expansion-of-irraflow-launch-to-southeastern-europe,c3256545